La FIGO est une organisation mondiale représentée par 139 sociétés membres, composée de quasiment un million de gynécologues et obstétriciens travaillant pour assurer la santé de toutes les femmes, ...
The IJGO Author Guidelines provide clear instructions for preparing manuscripts, before submitting them for consideration to ...
FIGO regularly issues statements and joint statements.
May 2019, FIGO released Guidelines to combat pre-eclampsia, and calls for all women to receive first-trimester screening. Read the Pre-eclampsia Guidelines here. 76,000 women and 500,000 babies die ...
We work together with our global network of world-renowned experts, to foster scientific and policy dialogues and disseminate the latest evidence in the field of women’s health and rights. Explore our ...
FIGO’s 2024-2025 free webinar series tackles the most pressing issues on women’s health and rights. Organised by FIGO’s Divisions and Committees, FIGO’s webinar series brings together women’s health ...
Each member society is committed to supporting FIGO's aim for women of the world to achieve the highest possible standards of physical, mental, reproductive and sexual health and wellbeing throughout ...
FIGO Divisions and Committees bring together experts from our member societies with other health care professionals focusing on specialist areas of obstetrics and gynaecology to encourage global ...
This website is owned and operated by The International Federation of Gynecology and Obstetrics, a company limited by guarantee registered in England Wales under company number 05498067 of 3 Waterloo ...
The Committee on Menstrual Disorders and Related Health Impacts focuses on the set of symptoms described as non-gestational abnormal uterine bleeding (AUB), including heavy menstrual bleeding (HMB).
The 2021 edition of the FIGO Cancer Report contains updates on the management of gynaecological cancers combined with pertinent papers on gynaecological oncology, which we hope the reader will find ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果